Endogenous Regulators of G Protein Signaling Differentially Modulate Full and Partial μ-Opioid Agonists at Adenylyl Cyclase as Predicted by a Collision Coupling Model
Open Access
- 19 February 2008
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 73 (5), 1538-1548
- https://doi.org/10.1124/mol.107.043547
Abstract
Regulator of G protein signaling (RGS) proteins accelerate the endogenous GTPase activity of Gαi/o proteins to increase the rate of deactivation of active Gα-GTP and Gβγ signaling molecules. Previous studies have suggested that RGS proteins are more effective on less efficiently coupled systems such as with partial agonist responses. To determine the role of endogenous RGS proteins in functional responses to μ-opioid agonists of different intrinsic efficacy, Gαi/o subunits with a mutation at the pertussis toxin (PTX)-sensitive cysteine (C351I) and with or without a mutation at the RGS binding site (G184S) were stably expressed in C6 glioma cells expressing a μ-opioid receptor. Cells were treated overnight with PTX to inactivate endogenous G proteins. Maximal inhibition of forskolin-stimulated adenylyl cyclase by the low-efficacy partial agonists buprenorphine and nalbuphine was increased in cells expressing RGS-insensitive GαoCIGS, Gαi2CIGS, or Gαi3CIGS compared with their GαCI counterparts, but the RGS-insensitive mutation had little or no effect on the maximal inhibition by the higher efficacy agonists DAMGO and morphine. The potency of all the agonists to inhibit forskolin-stimulated adenylyl cyclase was increased in cells expressing RGS-insensitive GαoCIGS, Gαi2CIGS, or Gαi3CIGS, regardless of efficacy. These data are comparable with predictions based on a collision coupling model. In this model, the rate of G protein inactivation, which is modulated by RGS proteins, and the rate of G protein activation, which is affected by agonist intrinsic efficacy, determine the maximal agonist response and potency at adenylyl cyclase under steady state conditions.Keywords
This publication has 31 references indexed in Scilit:
- Multiple receptor states are required to describe both kinetic binding and activation of neutrophils via N-formyl peptide receptor ligandsCellular Signalling, 2006
- Pleiotropic Phenotype of a Genomic Knock-In of an RGS-Insensitive G184S Gnai2 AlleleMolecular and Cellular Biology, 2006
- RGS Proteins: New Players in the Field of Opioid Signaling and Tolerance MechanismsAnesthesia & Analgesia, 2005
- Endogenous RGS Protein Action Modulates μ-Opioid Signaling through GαoPublished by Elsevier BV ,2003
- RGS12 and RGS14 GoLoco Motifs Are GαiInteraction Sites with Guanine Nucleotide Dissociation Inhibitor ActivityPublished by Elsevier BV ,2001
- Timing is everything: The role of kinetics in G protein activationLife Sciences, 2000
- The Regulator of G Protein Signaling RGS4 Selectively Enhances α2A-Adreoreceptor Stimulation of the GTPase Activity of Go1α and Gi2αPublished by Elsevier BV ,2000
- Regulators of G Protein Signaling 6 and 7Journal of Biological Chemistry, 1999
- Interdomain Interactions Regulate GDP Release from Heterotrimeric G ProteinsBiochemistry, 1999
- Hydrophobicity of Residue351 of the G Protein Gi1α Determines the Extent of Activation by the α2A-AdrenoceptorBiochemistry, 1998